Hopes for HIV vaccine buoyed by start of second big trial

LONDON, Nov 30 (Reuters) - Scientists announced the launch of another large HIV vaccine efficacy study on Thursday, fuelling hopes for a protective shot against the virus that causes AIDS, despite past disappointments.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.